Pregled bibliografske jedinice broj: 641616
ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia
ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia // Leukemia & lymphoma, 54 (2013), 6; 1171-1176 doi:10.3109/10428194.2012.742527 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 641616 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia
Autori
Šoljić, Violeta ; Beljan Perak, Renata ; Vukojević, Katarina ; Saraga-Babić, Mirna ; Bubalo, Pero ; Karan, Dragana ; Todorović, Jelena ; Batinić, Drago
Izvornik
Leukemia & lymphoma (1042-8194) 54
(2013), 6;
1171-1176
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
chronic lymphocytic leukemia; ZAP-70; proliferation
Sažetak
The expression of 70 kDa protein zeta-associated protein (ZAP-70) in chronic lymphocytic leukemia (CLL) has been used to detect those patients with more aggressive disease. The aim of this study was to determine the proliferative activity of ZAP-70(+) leukemic cells by immunocytochemical methods. The study was undertaken on native blood marrow (BM) and peripheral blood (PB) smears from 65 patients with CLL. ZAP-70 was expressed in leukemic cells of 35 patients (54%). We demonstrated that ZAP-70 immunoreactivity correlated with Rai 0–IV (p = 0.002) and Binet A–C stages (p < 0.001), total tumor mass (TTM score) (p < 0.001), β2-microglobulin (p = 0.006), atypical lymphocytes (p < 0.001) and proliferative activity in bone marrow and peripheral blood (p = 0.014, p = 0.002, respectively) using χ2 test and Mann–Whitney test. ZAP-70 protein expression is in direct correlation with the poorer prognostic parameters, which additionally confirms the successful method of detection of ZAP-70 expression. Higher Ki-67 expression in BM and PB smears of patients with ZAP-70(+) disease indicates higher proliferating compartments, which may contribute to poorer prognosis.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
214-1081347-0355 - Uloga PI3K/Akt i MAPK u regulaciji kemorezistencije leukemijskih stanica (Batinić, Drago, MZOS ) ( CroRIS)
216-2160528-0507 - Genski izražaj u ranom razvoju čovjeka (Saraga-Babić, Mirna) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
KBC Split,
Klinički bolnički centar Zagreb,
Medicinski fakultet, Split
Profili:
Drago Batinić
(autor)
Pero Bubalo
(autor)
Mirna Saraga-Babić
(autor)
Katarina Vukojević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE